Katie Snape

6.1k total citations
39 papers, 644 citations indexed

About

Katie Snape is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Katie Snape has authored 39 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 12 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Katie Snape's work include BRCA gene mutations in cancer (15 papers), Cancer Genomics and Diagnostics (9 papers) and Genomics and Rare Diseases (8 papers). Katie Snape is often cited by papers focused on BRCA gene mutations in cancer (15 papers), Cancer Genomics and Diagnostics (9 papers) and Genomics and Rare Diseases (8 papers). Katie Snape collaborates with scholars based in United Kingdom, United States and Germany. Katie Snape's co-authors include Richard C. Trembath, Julian Barwell, Deborah Ruddy, Wim Wuyts, Martin Zenker, Clare Turnbull, Wayne Lam, Diana Johnson, Margo Whiteford and Helen Hanson and has published in prestigious journals such as Blood, The Lancet Oncology and The American Journal of Human Genetics.

In The Last Decade

Katie Snape

35 papers receiving 640 citations

Peers

Katie Snape
Sarah A. Jackson United States
Nicolas Goardon France
Sonja Kiuru‐Kuhlefelt Finland
Bertil Johansson Sweden
C. Diana Jordan United States
Tim Ripperger Germany
Hanne Rose Denmark
Christine R. Bryke United States
Yosuke Komoto Japan
Ilse Chudoba Germany
Sarah A. Jackson United States
Katie Snape
Citations per year, relative to Katie Snape Katie Snape (= 1×) peers Sarah A. Jackson

Countries citing papers authored by Katie Snape

Since Specialization
Citations

This map shows the geographic impact of Katie Snape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Snape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Snape more than expected).

Fields of papers citing papers by Katie Snape

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Snape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Snape. The network helps show where Katie Snape may publish in the future.

Co-authorship network of co-authors of Katie Snape

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Snape. A scholar is included among the top collaborators of Katie Snape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Snape. Katie Snape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morton, Katherine, Lesley Turner, Rebecca H. Foster, et al.. (2025). Optimizing risk‐reducing surgery and aspirin decision aids for Lynch syndrome carriers using the person‐based approach: A think‐aloud interview study. Journal of Genetic Counseling. 34(4). e70089–e70089.
2.
Rowlands, Charlie F, Alice Garrett, Miranda Durkie, et al.. (2025). Availability of benign missense variant “truthsets” for validation of functional assays: Current status and a systematic approach. The American Journal of Human Genetics. 112(10). 2281–2294.
3.
Usher‐Smith, Juliet A., Abdul Badran, Andrea Forman, et al.. (2024). Patterns of referrals to regional clinical genetics services for women potentially at above-population level risk of breast cancer. PubMed. 2(1). 2–2. 1 indexed citations
4.
Huntley, Catherine, Bethany Torr, Angela George, et al.. (2024). Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling study. British Journal of General Practice. 74(746). e610–e618. 1 indexed citations
5.
Short, John Rennie, et al.. (2024). Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery. Familial Cancer. 23(4). 591–598. 1 indexed citations
6.
Abraham, Jean, Katie Snape, Katrina Tatton‐Brown, et al.. (2023). Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists. Clinical Medicine. 23(1). 9–15. 11 indexed citations
7.
Monje‐Garcia, Laura, Emma Kipps, Angela F. Brady, et al.. (2023). From diagnosis of colorectal cancer to diagnosis of Lynch syndrome: The RM Partners quality improvement project. Colorectal Disease. 25(9). 1844–1851. 4 indexed citations
8.
Badran, Abdul, et al.. (2023). Proactive familial cancer risk assessment: a service development study in UK primary care. BJGP Open. 7(4). BJGPO.2023.0076–BJGPO.2023.0076. 1 indexed citations
9.
10.
11.
12.
Joekes, Katherine, et al.. (2023). Evaluation of two Massive Open Online Courses (MOOCs) in genomic variant interpretation for the NHS workforce. BMC Medical Education. 23(1). 540–540. 4 indexed citations
13.
Bandlamudi, Chaitanya, Chey Loveday, Miika Mehine, et al.. (2022). Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. Annals of Oncology. 34(3). 215–227. 63 indexed citations
14.
Andreou, Avgi, Bryndís Yngvadóttir, Laia Bassaganyas, et al.. (2022). Elongin C (ELOC/TCEB1)-associated von Hippel–Lindau disease. Human Molecular Genetics. 31(16). 2728–2737. 20 indexed citations
15.
Snape, Katie, et al.. (2019). The new genomic medicine service and implications for patients. Clinical Medicine. 19(4). 273–277. 53 indexed citations
16.
Southgate, Laura, Maja Sukalo, Edward J. Taylor, et al.. (2015). Haploinsufficiency of the NOTCH1 Receptor as a Cause of Adams–Oliver Syndrome With Variable Cardiac Anomalies. Circulation Cardiovascular Genetics. 8(4). 572–581. 70 indexed citations
17.
Snape, Katie, Elise Ruark, Patrick Tarpey, et al.. (2012). Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer. Breast Cancer Research and Treatment. 134(1). 429–433. 36 indexed citations
18.
Snape, Katie, Deborah Ruddy, Martin Zenker, et al.. (2009). The spectra of clinical phenotypes in aplasia cutis congenita and terminal transverse limb defects. American Journal of Medical Genetics Part A. 149A(8). 1860–1881. 70 indexed citations
19.
20.
Snape, Katie, Michael Fahey, George McGillivray, et al.. (2006). Long-term survival in a child with severe congenital contractural arachnodactyly, autism and severe intellectual disability. Clinical Dysmorphology. 15(2). 95–99. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah A. Jackson Breakdown of academic impact, for papers by Nicolas Goardon Breakdown of academic impact, for papers by Sonja Kiuru‐Kuhlefelt Breakdown of academic impact, for papers by Bertil Johansson Breakdown of academic impact, for papers by C. Diana Jordan Breakdown of academic impact, for papers by Tim Ripperger Breakdown of academic impact, for papers by Hanne Rose Breakdown of academic impact, for papers by Christine R. Bryke Breakdown of academic impact, for papers by Yosuke Komoto Breakdown of academic impact, for papers by Ilse Chudoba
Rankless by CCL
2026